Literature DB >> 29933724

Reference values for maximum work rate in apparently healthy Dutch/Flemish adults: data from the LowLands fitness registry.

D J Van de Poppe1, E Hulzebos2,3, T Takken2,3.   

Abstract

Background: The peak oxygen uptake (VO2peak) test is the gold standard for cardiorespiratory fitness. However, the test is demanding, requiring sophisticated apparatus for measuring the oxygen uptake. Peak work rate (WRpeak) testing is a promising substitute for peak VO2peak testing. However, there is a paucity of research conducted to determine reference values (RVs) for WRpeak.
Methods: The database from the LowLands fitness registry was used, containing data from health checks from apparently healthy subjects among various professions. Exercise tests were performed using a cycle ergometer and a calibrated metabolic cart. Analysis was executed on 3463 subjects, 2868 male and 595 female. Reference values with corresponding centiles were developed using the LMS method.
Results: VO2peak and WRpeak where highly associated with Pearson's correlation of 0.9 (p = .001). Weight, height, maximum heart rate, and the respiratory exchange ratio had a positive significant effect (p < .001) on WRpeak, and age a negative significant effect, in both males and females. The following formulas were computed for RVs: WRpeak=-102+(1.5 * weight[kg])+(1.9 * height[cm])-(2.0 * age)-(sex * 60[M:0;V:1]) WRpeak/kg=2.45-(0.026 * weight[kg])+(0.024 * height[cm])-(0.024 * age)-(sex * 0.84 [M:0;V:1]) Conclusions: WRpeak can be used as a substitute for VO2peak when a respiratory gas-analysis system is not available. This study provides RVs for WRpeak and WRpeak/kg in a healthy Dutch/Flemish adult population using cycle ergometry. Further research is needed to obtain RVs for elderly subjects, specific diseases, ethnicities and ergometers.

Entities:  

Keywords:  Reference values; aerobic fitness; exercise test; motor activity; oxygen uptake

Year:  2018        PMID: 29933724     DOI: 10.1080/00015385.2018.1478763

Source DB:  PubMed          Journal:  Acta Cardiol        ISSN: 0001-5385            Impact factor:   1.718


  7 in total

1.  Cardiorespiratory fitness status of elite handball referees in Hungary.

Authors:  Máté Babity; Márk Zámodics; Bálint K Lakatos; Réka Rákóczi; Albert König; Anna Menyhárt-Hetényi; Alexandra Fábián; Anna Kiss; Márton Tokodi; Attila Kovács; Hajnalka Vágó; Béla Merkely; Orsolya Kiss
Journal:  PLoS One       Date:  2022-07-07       Impact factor: 3.752

2.  Oxygen Uptake Efficiency Slope is Strongly Correlated to VO2peak Long-Term After Arterial Switch Operation.

Authors:  Covadonga Terol Espinosa de Los Monteros; Roel L F Van der Palen; Mark G Hazekamp; Lukas Rammeloo; Monique R M Jongbloed; Nico A Blom; Arend D J Ten Harkel
Journal:  Pediatr Cardiol       Date:  2021-02-01       Impact factor: 1.655

3.  Exercise Capacity in Asymptomatic Adult Patients Treated for Coarctation of the Aorta.

Authors:  Elles J Dijkema; Gertjan Tj Sieswerda; Johannes M P J Breur; Felix Haas; Martijn G Slieker; Tim Takken
Journal:  Pediatr Cardiol       Date:  2019-08-07       Impact factor: 1.655

4.  Extended steep ramp test normative values for 19-24-year-old healthy active young adults.

Authors:  M S Werkman; B C Bongers; T Blatter; T Takken; H Wittink
Journal:  Eur J Appl Physiol       Date:  2019-11-08       Impact factor: 3.078

5.  Reference values for maximum oxygen uptake relative to body mass in Dutch/Flemish subjects aged 6-65 years: the LowLands Fitness Registry.

Authors:  Geertje E van der Steeg; Tim Takken
Journal:  Eur J Appl Physiol       Date:  2021-02-01       Impact factor: 3.078

6.  Generalized Joint Hypermobility and Anxiety in Adolescents and Young Adults, the Impact on Physical and Psychosocial Functioning.

Authors:  Janneke de Vries; Jeanine Verbunt; Janine Stubbe; Bart Visser; Stephan Ramaekers; Patrick Calders; Raoul Engelbert
Journal:  Healthcare (Basel)       Date:  2021-04-29

7.  Long-term effects of ivacaftor on nonpulmonary outcomes in individuals with cystic fibrosis, heterozygous for a S1251N mutation.

Authors:  M Marcella Burghard; G Gitte Berkers; S Sophie Ghijsen; Fm Francis Hollander-Kraaijeveld; Km Karin de Winter-de Groot; Ck Kors van der Ent; Hgm Harry Heijerman; T Tim Takken; Hj Erik Hulzebos
Journal:  Pediatr Pulmonol       Date:  2020-03-31
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.